PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Net Sales | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr | ₹6,315 Cr |
What is the latest Revenue of PIRAMAL PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹8,171 Cr |
Mar2023 | ₹7,082 Cr |
Mar2022 | ₹6,559 Cr |
Mar2021 | ₹6,315 Cr |
How is Revenue of PIRAMAL PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹8,171 Cr | 15.39 | |
Mar2023 | ₹7,082 Cr | 7.97 | |
Mar2022 | ₹6,559 Cr | 3.87 | |
Mar2021 | ₹6,315 Cr | - |
Compare Revenue of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,577.4 Cr | -3.1% | -8.7% | 36.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -3.1% |
-8.7% |
36.3% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses